Struan Henry Gray

Struan Henry Gray

Auto-generated profile, based on publicly available information

Struan Henry Gray

Salford Royal and The Christie NHS Foundation Trusts, Manchester, United Kingdom

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in American Society of Clinical Oncology Educational Book
Verified
Journal Article
Closed access
LGLisa Gudenkauf
Lisa Gudenkauf
SGStruan Gray
Struan Gray
BGBrian D. Gonzalez
Brian D. Gonzalez
ASAshwin Sachdeva
Ashwin Sachdeva
KAKaren Autio
Karen Autio
Androgen-deprivation therapy (ADT) is well established as the standard of care in metastatic prostate cancer (PCa) management; however, ADT has significant adverse effects (AEs) that must be addressed. This review aims to highlight opportunities to mitigate AEs of ADT and explore alternatives in PCa management. Specifically, we discuss behavioral and pharmacologic strategies for mitigating ADT AEs as well as ADT-sparing approaches for hormone-sensitive and castration-resistant PCa. Equipped with effective mitigation strategies and possible alternatives, clinicians and researchers can optimize health-related quality of life for patients currently receiving ADT for PCa and consider treatments that spare patients from AEs of ADT.

14 December 2020 in Clinical Case Reports: Open Access
Verified
Journal Article
Closed access
SGStruan Henry Gray
Struan Henry Gray
LLLing Lee
Ling Lee

7 October 2016 in The American Journal of Surgery
Verified
Journal Article
Closed access
PDF file
FCF. Cull
F. Cull
SGS. Gray
S. Gray
MJM. Johnstone
M. Johnstone
MGM. Gillespie
M. Gillespie
AJA. Johnston
A. Johnston

30 July 2020 in Journal of Clinical Urology
Verified
Journal Article
Closed access
PDF file
SGStruan Henry Gray
Struan Henry Gray
DWDaniel Wignall
Daniel Wignall
KSKatie Stocking
Katie Stocking
LLLing Lee
Ling Lee
MPMichael Pantelides
Michael Pantelides
AGAgapios Gkentzis
Agapios Gkentzis
Delayed presentation in acute testicular torsion increases risk of testicular loss. We investigated whether there is a delay in presentation with suspected torsion in patients from an ethnic minority. A retrospective audit of patients undergoing scrotal exploration for suspected torsion from September 2014 to September 2019 was completed. Notes were used to identify time between onset of pain and presentation to hospital. Patients’ ethnicity was identified through voluntary demographic information. Median time to presentation was compared between ethnic minorities and white British patients, as well as exploration findings. Ethnic minority patients (n=29) with suspected torsion presented significantly later with a median of 19 hours (range 1.3–192) compared to 4 hours (0.5–96) in white British patients (n=65). (p<0.001) In patients found to have torsion with or without testicular loss, ethnic minority patients (n=18) presented at a median of 17.5 hours (3.1–192) compared to 3 hours (0.5–84) in white British patients (n=33), a statistically significant delay (p<0.001). The relative risk of ethnic minorities requiring orchidectomy when presenting with torsion was 12.83. In our population, ethnic minorities present later with acute scrotal pain, increasing their risk of testicular loss. More study is required to identify causes of delayed presentation in these patients with the aim of improving health education. 3

20 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DSDavid Shackley
David Shackley
SGStruan Henry Gray
Struan Henry Gray
SPSusannah Penney
Susannah Penney
LGLisa Galligan-Dawson
Lisa Galligan-Dawson
FHFreya Howle
Freya Howle
CHChristopher Harrison
Christopher Harrison
Introduction: The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has put an unprecedented burden on global healthcare, including detrimental implications for the volume and provision of surgical services. The aim of this audit was to assess if the planned surgical cancer care (both diagnostic for possible cancer, and treatment of known cancer) during this period of widespread community and hospital based COVID-19 infection resulted in patients acquiring symptomatic COVID-19 as a consequence of their surgical admission, and if so, what the impact on patients was. Methods: A prospective audit of all patients undergoing elective cancer surgery in Greater Manchester operated on between 01/05/2020 and 31/06/2020 was undertaken after the introduction of specific peri operative COVID safety measures across Greater Manchester cancer surgical cells. The COVID related outcomes for all cancer patients operated on in Greater Manchester were recorded. Results: Of the 1501 patients undergoing surgery, one (<0.1%) was diagnosed with COVID-19 in hospital within 14 days of surgery. This patient did not require admission to critical care due to post-operative COVID-19 diagnosis, and there was no associated mortality related to post-operative COVID-19 infection. Conclusion: The use of peri operative COVID-19 infection prevention strategies has allowed for the safe continuation of elective cancer surgery during this pandemic in all surgical units, without significant additional COVID-19 related morbidity or mortality.